Dr. Reddy's Laboratories Limited $RDY reported quarterly revenue of $807.2 million, down 19.3% from a year earlier. The company’s gross profit and operating profit both moved sharply lower, with operating profit falling to a loss of $819.3 million.
Net income attributable to common shareholders came in at $46.8 million, while diluted earnings per share were $0.06, both declining year over year. Cash from operating activities totaled $150.1 million, and capital spending on property, plant and equipment was $40.5 million.
- Revenue: $807.2 million, down 19.3%
- Net income: $46.8 million, down 71.7%
- Diluted EPS: $0.06, down 70.0%
- Operating cash flow: $150.1 million
- Cash and cash equivalents: $164.4 million
The balance sheet showed cash and cash equivalents of $164.4 million, up 56.5% from a year ago, while total liabilities rose 10.0% to $2.1 billion. The stock fell 2.74% from the market open.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Dr. Reddy's Laboratories Limited Hedge Fund Activity
We have seen 113 institutional investors add shares of Dr. Reddy's Laboratories Limited stock to their portfolio, and 93 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FRANKLIN RESOURCES INC added 2,856,094 shares (+inf%) to their portfolio in Q1 2026, for an estimated $39,556,901
- ALLIANCEBERNSTEIN L.P. added 2,511,928 shares (+8384.0%) to their portfolio in Q1 2026, for an estimated $34,790,202
- MARSHALL WACE, LLP added 2,148,050 shares (+416.1%) to their portfolio in Q1 2026, for an estimated $29,750,492
- BLACKROCK, INC. added 1,289,122 shares (+12.5%) to their portfolio in Q1 2026, for an estimated $17,854,339
- BNP PARIBAS FINANCIAL MARKETS removed 968,595 shares (-23.3%) from their portfolio in Q1 2026, for an estimated $13,415,040
- ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. added 843,218 shares (+4.9%) to their portfolio in Q2 2026, for an estimated $12,218,228
- CAISSE DE DEPOT ET PLACEMENT DU QUEBEC removed 677,700 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $9,386,145
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
